Stock Comparison · Live Data
REGN vs VRTX
Side-by-side comparison of Regeneron Pharmaceuticals Inc (REGN), Vertex Pharmaceuticals Inc (VRTX) — live price, market cap, day change, and sector classification.
REGN vs VRTX — which stock is the better buy?
Vertex Pharmaceuticals Inc (VRTX) leads this comparison by market capitalization at $107.83B. REGN is today's top mover with a +0.97% move, while VRTX sees the highest trading volume at 777.69K shares.
Whether REGN vs VRTX is the better investment for your portfolio depends on your time horizon, risk tolerance, and existing exposure. ArbibX runs Claude AI across thousands of US stocks daily and surfaces the most actionable picks with confidence scores and target prices. For a personalized analysis on REGN vs VRTX, use the in-app "Ask Claude" assistant — it sees the live prices from this page plus your portfolio context.
Per-stock breakdown
- REGN — Regeneron Pharmaceuticals Inc trades at $708.19, day change +0.97%, pharmaceutical preparations sector, market cap $73.54B.
- VRTX — Vertex Pharmaceuticals Inc trades at $427.18, day change +0.77%, pharmaceutical preparations sector, market cap $107.83B.
Frequently asked
Which is the better stock — REGN vs VRTX?
It depends on your goals. Vertex Pharmaceuticals Inc (VRTX) has the larger market cap at $107.83B. Today REGN is the strongest performer (+0.97%). For a qualitative read on each name use the AI Top 15 tab on ArbibX.
What is the current price of REGN and VRTX?
REGN is trading at $708.19 (+0.97% on the day). VRTX is trading at $427.18 (+0.77% on the day). Live prices update every minute on the ArbibX terminal.
How does ArbibX compare stocks?
ArbibX pulls live snapshot data from Polygon.io and pairs it with Claude-powered AI analysis. Comparison pages show price, market cap, day change, sector, and key technicals side by side. The deeper analysis (target prices, signals, risk notes) lives on each ticker's dedicated page.
Not financial advice · For informational purposes only · Data via Polygon.io